MEN1 mutations in Hürthle cell (oncocytic) thyroid carcinoma.

CONTEXT AND OBJECTIVE Oncocytic thyroid carcinoma, also known as Hürthle cell thyroid carcinoma, accounts for only a small percentage of all thyroid cancers. However, this malignancy often presents at an advanced stage and poses unique challenges to patients and clinicians. Surgical resection of the tumor accompanied in some cases by radioactive iodine treatment, radiation, and chemotherapy are the established modes of therapy. Knowledge of the perturbed oncogenic pathways can provide better understanding of the mechanism of disease and thus opportunities for more effective clinical management. DESIGN AND PATIENTS Initially, two oncocytic thyroid carcinomas and their matched normal tissues were profiled using whole genome sequencing. Subsequently, 72 oncocytic thyroid carcinomas, one cell line, and five Hürthle cell adenomas were examined by targeted sequencing for the presence of mutations in the multiple endocrine neoplasia I (MEN1) gene. RESULTS Here we report the identification of MEN1 loss-of-function mutations in 4% of patients diagnosed with oncocytic thyroid carcinoma. Whole genome sequence data also revealed large regions of copy number variation encompassing nearly the entire genomes of these tumors. CONCLUSION Menin, a ubiquitously expressed nuclear protein, is a well-characterized tumor suppressor whose loss is the cause of MEN1 syndrome. Menin is involved in several major cellular pathways such as regulation of transcription, control of cell cycle, apoptosis, and DNA damage repair pathways. Mutations of this gene in a subset of Hürthle cell tumors point to a potential role for this protein and its associated pathways in thyroid tumorigenesis.

[1]  N. Socci,et al.  Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy. , 2013, The Journal of clinical endocrinology and metabolism.

[2]  M. Xing,et al.  Molecular pathogenesis and mechanisms of thyroid cancer , 2013, Nature Reviews Cancer.

[3]  S. Roman,et al.  Hurthle cell carcinoma , 2013, Cancer.

[4]  Murim Choi,et al.  Identification of somatic mutations in parathyroid tumors using whole-exome sequencing. , 2012, The Journal of clinical endocrinology and metabolism.

[5]  E. Jordanova,et al.  Genome Haploidisation with Chromosome 7 Retention in Oncocytic Follicular Thyroid Carcinoma , 2012, PloS one.

[6]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[7]  Mingming Jia,et al.  COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..

[8]  Stephanie L. Lee,et al.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[9]  Z. Baloch,et al.  The thyroid Hürthle (oncocytic) cell and its associated pathologic conditions: a surgical pathology and cytopathology review. , 2009, Archives of pathology & laboratory medicine.

[10]  C. Béroud,et al.  Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein , 2002, Human mutation.

[11]  M. Sobrinho-Simões,et al.  Hürthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance , 2000, Virchows Archiv.

[12]  S. Forbes,et al.  Characterization of mutations in patients with multiple endocrine neoplasia type 1. , 1998, American journal of human genetics.

[13]  F. Collins,et al.  Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. , 1997, Human molecular genetics.

[14]  F. Collins,et al.  Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. , 1997, Cancer research.

[15]  F. Collins,et al.  Somatic mutation of the MEN1 gene in parathyroid tumours , 1997, Nature Genetics.

[16]  F. Collins,et al.  Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. , 1997, Human molecular genetics.

[17]  Y Wang,et al.  Positional cloning of the gene for multiple endocrine neoplasia-type 1. , 1997, Science.

[18]  L. Sobin,et al.  The WHO histological classification of thyroid tumors: A commentary on the second edition , 1989, Cancer.